Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction

Publisher： Karger

E-ISSN： 1660-3818|38|1|55-64

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.38, Iss.1, 2011-01, pp. : 55-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenge study of the pathogen reduction capacity of the THERAFLEX MB‐Plasma technology

By  

VOX SANGUINIS, Vol. 109, Iss. 2, 2015-08 ,pp. : 129-137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 2, 2009-03 ,pp. : 122-127

Karger

Access to resources Recommend Favorite

The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 65-70

Karger

Access to resources Recommend Favorite

UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 43-54

Karger

Access to resources Recommend Favorite

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 8-18

Karger

Access to resources Recommend Favorite